Results 191 to 200 of about 604,873 (268)
Bona Fide Intersegmental Plane Hepatectomy Along the Glissonean Branches (BIPHG)
ABSTRACT This review traces the author's personal journey over three decades in the evolution of liver resection techniques, culminating in the proposal of the Bona Fide Intersegmental Plane Hepatectomy Along Glissonean Branches (BIPHG). Beginning with pioneering experiences in laparoscopic and robotic liver surgeries, the author highlights key ...
Go Wakabayashi, Taiga Wakabayashi
wiley +1 more source
This multicenter retrospective cohort study compared mid‐term oncological outcomes between intracorporeal anastomosis (IA) and extracorporeal anastomosis (EA) in minimally invasive colectomy for colon cancer using propensity score–matched data from 2018 to 2022.
Takuya Takami +9 more
wiley +1 more source
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer. [PDF]
Sinicrope FA +22 more
europepmc +1 more source
In this retrospective cohort of 3487 patients with CRC, history of CCY was associated with significantly worse prognosis in patients with proximal CRC but not in those with distal CRC. This differential prognostic impact showed a statistically significant interaction between tumor location and history of CCY and remained robust after PSM.
Masashi Tsunematsu +9 more
wiley +1 more source
RETRACTION: LncRNA NEAT1/mir-185-5p/igf2 Axis Regulates the Invasion and Migration of Colon Cancer. [PDF]
europepmc +1 more source
lncRNA AL445238.2‑USP4 axis regulates cell survival and stemness in colon cancer. [PDF]
Lin H +5 more
europepmc +1 more source
This study compared short‐term outcomes of robot‐assisted versus laparoscopic colectomy for colon cancer using 1:1 propensity score matching. Among 218 matched pairs, robot‐assisted colectomy was associated with reduced blood loss, fewer conversions to open surgery, lower overall complication rates, and shorter hospital stays, despite longer operative ...
Akira Inoue +9 more
wiley +1 more source
CXCL14 Inhibits Colon Cancer Progression by Modulating Tumor Cell Invasion and Immune Microenvironment. [PDF]
Zhang Y +5 more
europepmc +1 more source
This review summarizes key advances from 2024 to 2025 that are reshaping esophageal cancer surgery toward a strategy‐oriented, personalized paradigm through the integration of immunotherapy, population aging, and intelligent technologies. Adjuvant nivolumab after neoadjuvant chemoradiotherapy remains the only perioperative approach with durable benefit,
Shuichiro Oya +2 more
wiley +1 more source
Ureteroarterial Fistula Secondary to External Iliac Artery Pseudoaneurysm in a Patient With Metastatic Colon Cancer. [PDF]
Patacsil S, McKeon B.
europepmc +1 more source

